UNIQURE NV's ticker is QURE and the CUSIP is N90064101. A total of 160 filers reported holding UNIQURE NV in Q3 2023. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $46,000 | -28.1% | 2,477 | -28.3% | 0.00% | -25.0% |
| Q2 2022 | $64,000 | +137.0% | 3,457 | +128.5% | 0.00% | +300.0% |
| Q1 2022 | $27,000 | +2600.0% | 1,513 | +4943.3% | 0.00% | – |
| Q3 2021 | $1,000 | – | 30 | +900.0% | 0.00% | – |
| Q2 2021 | $0 | – | 3 | 0.0% | 0.00% | – |
| Q1 2021 | $0 | – | 3 | -72.7% | 0.00% | – |
| Q4 2020 | $0 | -100.0% | 11 | -74.4% | 0.00% | – |
| Q3 2020 | $2,000 | 0.0% | 43 | 0.0% | 0.00% | – |
| Q2 2020 | $2,000 | 0.0% | 43 | -4.4% | 0.00% | – |
| Q1 2020 | $2,000 | -33.3% | 45 | +4.7% | 0.00% | – |
| Q4 2019 | $3,000 | – | 43 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 155,500 | $11,803,000 | 2.66% |
| Aquilo Capital Management, LLC | 901,490 | $16,290,000 | 2.39% |
| Nantahala Capital Management | 2,811,459 | $50,803,000 | 2.25% |
| Privium Fund Management B.V. | 493,229 | $8,913,000 | 1.97% |
| 683 Capital Management, LLC | 1,355,000 | $24,485,000 | 1.31% |
| Henry James International Management Inc. | 125,622 | $2,270,000 | 0.90% |
| Integral Health Asset Management, LLC | 170,000 | $3,072,000 | 0.80% |
| Nantahala Capital Management | 890,000 | $16,082,000 | 0.71% |
| Sonic Fund II, L.P. | 50,000 | $904,000 | 0.51% |
| Voss Capital, LLC | 70,000 | $1,265,000 | 0.40% |